When was FREDUN founded?

FREDUN was founded in 1987 and raised its 1st funding round 30 years after it was founded.

Where is FREDUN located?

FREDUN is headquartered in Mumbai, India. It is registered at 11th Floor, Tower A, Urmi Estate, 95, Ganpatrao Kadam Marg, Lower Parel (W), Delisle Road, Mumbai, Mumbai, Maharashtra, India, 400013.

Who is the current CEO of FREDUN?

Fredun Nariman Medhora of FREDUN. They have also founded 1 company.

Which legal entities is FREDUN associated with?

FREDUN is associated with FREDUN PHARMACEUTICALS LTD and 1 other.

How many employees does FREDUN have?

As of Apr 30, 2026, FREDUN has 542 employees, reflecting a 25% year-over-year growth in headcount.

Is FREDUN a funded company?

FREDUN is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Jun 20, 2017.

When was the latest funding round of FREDUN?

FREDUN's latest funding was a $***** Post IPO round on Nov 15, 2025, with participation from 3 investors. Its primary sector is Traditional Pharmaceuticals. In India, the Traditional Pharmaceuticals sector has seen $800M in funding in 2026 to date.

What is the annual revenue of FREDUN?

Annual revenue of FREDUN is between ₹500 Cr and ₹1,000 Cr as on Mar 31, 2026

Where does FREDUN rank among its competitors?

FREDUN ranks 50th amongst 1239 active competitors, of which 43 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was FREDUN, which secured $11M in Nov, 2025.

Who are the top competitors of FREDUN?

FREDUN's top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, FREDUN secured the most recent funding round in November, 2025.

FREDUN - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Manufacturer of pharmaceutical formulations and orthopedic mobility products. It is a diversified healthcare company that manufactures pharmaceutical formulations and produces orthopedic and mobility support devices. Its pharmaceutical arm develops and supplies a range of generic and branded medicines. The mobility division offers a portfolio of orthotic braces and support systems for joint and limb rehabilitation.

Website: fredungroup.com
Email ID: *****@fredungroup.com
Phone Number: +91 **********
Registered Address: 11th Floor, Tower A, Urmi Estate, 95, Ganpatrao Kadam Marg, Lower Parel (W), Delisle Road, Mumbai, Mumbai, Maharashtra, India, 400013

Key Metrics

Founded Year

1987

Location

Mumbai, India

Stage

Public

Latest Funding Round

Post IPO, Nov 15, 2025, $*****

Investors

Nikhil Kishorchandra Vora & 17 more

Ranked

50^th among 1239 active competitors

Annual Revenue

₹500 - ₹1,000 Cr as on Mar 31, 2026

Employee Count

542 as on Apr 30, 2026

Investment & Acquisitions

Wagr

Similar Companies

Teva Pharmaceuticals & 1463 more

Exit Details

Public

View FREDUN's full profile

FREDUN is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
FREDNA DENTAL SYSTEMS PRIVATE LIMITED CIN: U85190MH2022PTC377214 , India, Active	Feb 21, 2022	₹10 - ₹50 Cr (As on Mar 31, 2025)	40 (As on May 01, 2026)
FREDUN PHARMACEUTICALS LTD CIN: L24239MH1987PLC043662 , India, Active	Jun 08, 1987	₹500 - ₹1,000 Cr (As on Mar 31, 2026)	502 (As on Apr 30, 2026)

FREDUN got listed on Mar 21, 2016.

Click here to take a look at FREDUN's IPO in detail

FREDUN has raised funding over 3 rounds. Its first funding round was on Jun 20, 2017. Its latest funding round was a Post IPO round on Nov 15, 2025 for $*****. 3 investors participated in its latest round. FREDUN has 6 institutional investors and 12 angel investors.

Here is the list of recent funding rounds of FREDUN:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 15, 2025	9359159	Post IPO	5291495	4665776	3000318	2534717
Sep 21, 2021	2402208	Post IPO	8068259	6664934	9122337	Systematix & 4 more
Jun 20, 2017	7571501	Post IPO	9451042	5017179	3116556	8258256

Access funding benchmarks and valuations. Sign up today!

View details of FREDUN's funding rounds and investors

The founders of FREDUN are Fredun Nariman Medhora and Daulat Nariman Medhora. Fredun Nariman Medhora is the CEO of FREDUN.

Here are the details of FREDUN's key team members:

Fredun Nariman Medhora: Co-Founder, CEO & MD of FREDUN. They serve on the board of 1 company.
Contact Info: 1 email address
Daulat Nariman Medhora: Co-Founder of FREDUN. They serve on the board of 1 company.

FREDUN's Board of Directors

FREDUN's board has 6 active members. Fredun Nariman Medhora, Daulat Nariman Medhora and Daisy Cyril Dsouza are part of team and Pooja Narendra Sanghavi, Sonal Dharmin Desai and Anshu Gyan Agarwal are independent board members.

Here is the list of FREDUN's board of directors:

Name	Type	Representing	Status	Duration
Fredun Nariman Medhora	Team	-	Current	20y 1m
Daulat Nariman Medhora	Team	-	Current	39y 4m
uropzk{	Team	-	Current	6y 8m
Pooja Narendra Sanghavi	Independent board member	-	Current	0y 10m
xyxtpvf	Independent board member	-	Current	8y 8m
rjxhlfc	Independent board member	-	Current	6y 6m

View details of FREDUN's Founder profiles and Board Members

FREDUN's employee count trend

FREDUN has 542 employees as of Apr 26. The total employee count is 25.0% more than what it was in Apr 25. Here is FREDUN's employee count trend over the years:

Uncover FREDUN's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of FREDUN include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of FREDUN, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
50th	FREDUN 1987, Mumbai (India), Public	Manufacturer of pharmaceutical formulations and orthopedic mobility products	-	Capri Loans, Alchemy Capital Management & 16 others	58/100